Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab [RoActemra/Actemra];   Drug: tocilizumab [RoActemra/Actemra]
Sponsor:   Hoffmann-La Roche
Completed - verified July 2011